Lipoprotein (a) Management: Lifestyle and Hormones

Author(s): Antonio Garcia-Rios, Ana Leon-Acuna, Jose Lopez-Miranda, Pablo Perez-Martinez*

Journal Name: Current Medicinal Chemistry

Volume 24 , Issue 10 , 2017

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer
Call for Editor


Cardiovascular disease (CVD) continues to be the first cause of mortality in developed countries. Moreover, far from diminishing, the cardiovascular risk factors leading towards the development of CVD are on the rise. Therefore, the preventive and therapeutic management which is currently in place is clearly not enough to stop this pandemic. In this context, a major resurgence in interest in lipoprotein (a) [Lp(a)] has occurred in light of its association with CVD. This series aims to review the basic and clinical aspects of Lp(a) biology. Specifically, the present review considers the current situation regarding the influence of lifestyle, hormones and other physiological or pathological conditions on Lp(a) plasma concentrations which might mitigate the harmful effects of this lipoprotein.

Keywords: Lipoprotein (a), cardiovascular disease, lifestyle, hormones, diet, exercise.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2017
Published on: 24 January, 2017
Page: [979 - 988]
Pages: 10
DOI: 10.2174/0929867324666170124144427
Price: $65

Article Metrics

PDF: 36
PRC: 1